Chinese english Germany Japanese Korea

4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI)

4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI) Struktur
99095-09-7
CAS-Nr.
99095-09-7
Englisch Name:
4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI)
Synonyma:
(3aR,4S,7R,7aS)-2-(4-bromobutyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione;4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI)
CBNumber:
CB58184758
Summenformel:
C13H18BrNO2
Molgewicht:
300.2
MOL-Datei:
99095-09-7.mol
Request For Quotation

4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI) Eigenschaften

Siedepunkt:
173-180 °C(Press: 0.04 Torr)
Dichte
1.448±0.06 g/cm3(Predicted)
pka
-1.45±0.20(Predicted)

Sicherheit

4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Tandospirone citrate

4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangzhou Juntang Technology Co., Ltd 020-36607679 13502246435
 sales@dmstandards.com China 10945 58
Scinova Biotech(Guangzhou) Co., Ltd. 13268215580
 scinova_sales@163.com China 7023 58
Shaanxi Dideu Newmaterial Co., Ltd. 029-87576359 15353716720
 1039@dideu.com China 10009 58
Henan Vcommend Consultrading Co., Ltd. 13393721940
 sales@vcommend.com China 9962 58
  • 4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-(4-bromobutyl)hexahydro-, (3aα,4β,7β,7aα)- (9CI)
  • (3aR,4S,7R,7aS)-2-(4-bromobutyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
  • 99095-09-7
Copyright 2019 © ChemicalBook. All rights reserved